In this current work, the n-hexane fraction from an ethanolic extract of pulverized peel of Ipomoea batatas Lam was subjected to chromatographic fractionation. Consequently, the fractions were investigated for their anticancer potential using the Sulforhodamine-B assay. Chromatographic fractionation led to n-hexane sub-fractions with greater anticancer potential. The study highlights the peel of Ipomoea batatas Lam as a rich dietary source of natural anticancer molecules which may be developed into nutraceuticals or serve as new leads in anticancer therapy.
Introduction
Cancer has been identified as a major cause of death in various parts of the world including the United States disease [1] . Despite the fact that several chemical treatments such as doxorubicine exist for this disease [2] , the observed toxicity of such drugs contributes greatly to the current search for more natural product alternatives which may offer more convenient treatment [3] . Sweet potato is an important bio-resource from which several medicinal compounds have been isolated and characterized. Following the notable discovery of the Batatins by Escalante-Sanchez, et al. [4] , we made several attempt to valorize sweet potato peels [5] [6] [7] and recently reported a bioassay guided fractionation/isolation of a cerebroside from the peels of a white skinned variety of sweet potato [8] .
However, several chromatographic fractions which exhibited anticancer activity were not reported therein. Therefore, we herein present the chromatographic fractionation and the anticancer potential of these fractions which could be good starting point for HPLC isolation of novel anticancer agents. 
Experimental Design, Materials and Methods

Material
Fractionation
The extract was initially fractionated into n-hexane, ethyl acetate, butanol and water. The n-hexane fraction was afterwards fractionated chromatographically, using a gradient 
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Sulforhodamine B assay
The fractions were investigated for their inhibitory potential against Colon 1-DLD-1, Colon-2-SW-620, Breast-1-MCF-7,
Breast-2-MDA-MB-231, Lung-A549 and Head and neck-FaDu (American Type Culture Collection, USA) according to the method described by Shagun et al. [9] .
Results and Discussion
The 
